Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Arcturus Therapeutics and Duke-NUS Medical School partner to develop a coronavirus (COVID-19) vaccine using STARR Technology
doi: 10.1186/s13195-017-0250-1 73 YassineH
Therapeutic potential of synthetic human -Defensin 1 short motif Pep-B on lipopolysaccharide-stimulated human dental pulp stem cells
[29] found a modest but significant reduction in headache risk with tirzepatide: by 24 months, the risk of having headaches was ~ 20% lower in the tirzepatide group compared to controls (RR 0.803, 95% CI 0.6680.966)
Once-weekly semaglutide produced sustained, clinically meaningful weight loss in people with obesity. (Wilding, New England Journal of Medicine )
US$ 21.43
US$ 29.72
US$ 28.33
US$ 22.16
US$ 21.30
US$ 22.46
US$ 27.14
